Comments
Shares of Strides Arcolab fell over 5 per cent today after the government has rejected the company’s proposal to issue shares to non-resident and resident equity shareholders of Shasun Pharmaceuticals.
The scrip declined by 5.4 per cent to Rs 1,090.80 on the BSE. On the NSE, the scrip lost 5 per cent to Rs 1,095.25.
The government had yesterday rejected the proposal from Strides Arcolab for issuing shares to non-resident and resident equity shareholders of Shasun Pharmaceuticals Ltd under a scheme of merger.
On the other hand, proposals for f oreign direct investment amounting to around Rs 4,000 crore by four pharma and medical devices firms, including Torrent Pharmaceuticals and Biocon’s research services arm Syngene, were yesterday approved by the government.
Meanwhile, in the broader market, the BSE 30-share Sensex was trading at 27,083.51, up 250 points.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.